Home2022
2022 marzo
Credibly reintermediate backend ideas for cross-platform models. Continually reintermediate integrated processes through technically sound intellectual capital. Holistically foster superior methodologies without market-driven best practices.
Multiplex Molecular Diagnostics, S.L. is a startup company belonging to the Brill group of companies. Created in 2022 is focused on the development, registration, industrialization and commercialization of Advanced IVD Molecular Diagnostics systems.
Copyright 2022, Multiplex Molecular Diagnostic, S.L.. All rights reserved. Privacy Policy, Legal Notice, Cookies Policy.
